SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-18-000016
Filing Date
2018-05-16
Accepted
2018-05-16 16:42:46
Documents
1
Period of Report
2018-05-10
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K amrx-8kx5x16x2018.htm 8-K 32381
  Complete submission text file 0001723128-18-000016.txt   33452
Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 510-240-6000
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 18840472
SIC: 2834 Pharmaceutical Preparations